Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Bicalutamide is more effective and safer than spironolactone for treating female hair loss.

Iron supplements may improve hair loss satisfaction even if initial iron levels are normal.

Most patients know about minoxidil for hair loss, but concerns about its use and effectiveness affect their decision to use it.

The research suggests that SFRP2 and PTGDS proteins might be indicators of female pattern hair loss and could contribute to hair loss.

5% Azelaic acid is as effective as 2% Minoxidil for female pattern hair loss and could be an alternative for those allergic to Minoxidil or pregnant.

Transgender patients face unique skin issues due to hormone treatments and surgeries.

Most adult women experiencing hair loss are aged 21-40, with the most common type being female pattern hair loss. Trichoscopy is a useful tool for diagnosing different types of hair loss.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

A patient with untreated congenital adrenal hyperplasia had large benign tumors in her adrenal glands removed, improving her symptoms.

Finasteride may help treat female hair loss, but has risks.

A 44-year-old woman with Down's syndrome was diagnosed with both rheumatoid and gouty arthritis and treated with multiple medications.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Three patients suffered severe health issues due to not getting enough vitamins and minerals after weight-loss surgery.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Higher levels of certain nerve-related proteins are linked to hair loss in women with scalp pain.

Genetic response to androgens is key in female pattern baldness, not SHBG levels.

Irisin and betatrophin levels change differently in PCOS, which may help assess metabolic risks.

Many patients with hidradenitis suppurativa also have severe acne and pilonidal cysts, often linked to other health problems.

Women with acne and hair loss, even if they have regular periods, often have polycystic ovary syndrome.

Women with PCOS are more likely to experience depression and have a negative body image compared to women without PCOS.

Oral contraceptives with cyproterone acetate improved quality of life for women with PCOS more than those with levonorgestrel.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

Hirsutism and acanthosis nigricans are reliable skin signs of PCOS and suggest the need for further tests for related health issues.

The author believes that giving medical conditions official names can sometimes overwhelm or scare patients.

Topical Valproic acid and 5% Minoxidil both significantly increase hair count in Female Pattern Hair Loss, with similar side effects.

Medical treatments like minoxidil and finasteride are important for improving hair loss and quality of life.

Older women taking spironolactone for hair loss may need yearly potassium checks due to a higher risk of hyperkalemia.